Deep-Learning–Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics DataZixiao Lu, Siwen Xu, Wei Shao, Yi Wu, Jie Zhang, Zhi Han, Qianjin Feng, Kun Huang Nov 2020 JCO Clinical Cancer InformaticsSee moreSee lessThis abstract is currently unavailable
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET TrialStephen Johnston, Shannon Puhalla, Duncan Wheatley, Alistair Ring, Peter Barry, Chris Holcombe, Jean Francois Boileau, Louise Provencher, André Robidoux, Mothaffar Rimawi, Stuart A. McIntosh, Ibrahim Shalaby, Robert C. Stein, Michael Thirlwell, David Dolling, James Morden, Claire Snowdon, Sophie Perry, Chester Cornman, Leona M. Batten, Lisa K. Jeffs, Andrew Dodson, Vera Martins, Arjun Modi, C. Kent Osborne, Katherine L. Pogue-Geile, Maggie Chon U Cheang, Norman Wolmark, Thomas B. Julian, Kate Fisher, Mairead MacKenzie, Maggie Wilcox, Cynthia Huang Bartlett, Maria Koehler, Mitch Dowsett, Judith M. Bliss, MSc, Samuel A. Jacobs Jan 2019 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Defining Risk of Late Recurrence in Early-Stage Estrogen Receptor–Positive Breast Cancer: Clinical Versus Molecular ToolsJulia Foldi, Tess O’Meara, Michal Marczyk, Tara Sanft, Andrea Silber, Lajos Pusztai Jun 2019 Journal of Clinical Oncology
Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort StudyThomas P. Ahern, Anne Broe, Timothy L. Lash, Deirdre P. Cronin-Fenton, Sinna Pilgaard Ulrichsen, Peer M. Christiansen, Bernard F. Cole, Rulla M. Tamimi, Henrik Toft Sørensen, Per Damkier Jul 2019 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Cyclin E mRNA: Assessing Cyclin-Dependent Kinase (CDK) Activation State to Elucidate Breast Cancer Resistance to CDK4/6 InhibitorsSarat Chandarlapaty, Pedram Razavi May 2019 Journal of Clinical Oncology
Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAMMatthew P. Goetz, Vera J. Suman, Yusuke Nakamura, Kazuma Kiyotani, V. Craig Jordan, James N. Ingle Aug 2019 Journal of Clinical Oncology
Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)E. Shelley Hwang, Terry Hyslop, Laura H. Hendrix, Stephanie Duong, Isabelle Bedrosian, Elissa Price, Abigail Caudle, Tina Hieken, Joseph Guenther, Clifford A. Hudis, Eric Winer, Alan P. Lyss, Diana Dickson-Witmer, Richard Hoefer, David W. Ollila, Timothy Hardman, Jeffrey Marks, Yunn-Yi Chen, Gregor Krings, Laura Esserman, Nola Hylton Apr 2020 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
CYP2D6 Genotype–Guided Tamoxifen Dosing in Hormone Receptor–Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase II StudyKenji Tamura, Chiyo K. Imamura, Toshimi Takano, Shigehira Saji, Takeharu Yamanaka, Kan Yonemori, Masato Takahashi, Junji Tsurutani, Reiki Nishimura, Kazuhiko Sato, Akira Kitani, Naoto T. Ueno, Taisei Mushiroda, Michiaki Kubo, Yasuhiro Fujiwara, Yusuke Tanigawara Feb 2020 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast CancerPhilip D. Poorvu, Shari I. Gelber, Shoshana M. Rosenberg, Kathryn J. Ruddy, Rulla M. Tamimi, Laura C. Collins, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Debbie M. Jakubowski, Christy Russell, Eric P. Winer, Ann H. Partridge Mar 2020 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline UpdateKimberly H. Allison, M. Elizabeth H. Hammond, Mitchell Dowsett, Shannon E. McKernin, Lisa A. Carey, Patrick L. Fitzgibbons, Daniel F. Hayes, Sunil R. Lakhani, Mariana Chavez-MacGregor, Jane Perlmutter, Charles M. Perou, Meredith M. Regan, David L. Rimm, W. Fraser Symmans, Emina E. Torlakovic, Leticia Varella, Giuseppe Viale, Tracey F. Weisberg, Lisa M. McShane, Antonio C. Wolff Apr 2020 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Molecular Predictive and Prognostic Markers in Locoregional ManagementEleftherios P. Mamounas, Melissa P. Mitchell, Wendy A. Woodward Jul 2020 Journal of Clinical Oncology
Pharmacogenomics and Endocrine Therapy in Breast CancerDaniel F. Hayes, James M. Rae Feb 2020 Journal of Clinical Oncology
Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5 Mitch Dowsett , Ivana Sestak , Meredith M. Regan , Andrew Dodson , Giuseppe Viale , Beat Thürlimann , Marco Colleoni , Jack Cuzick Jul 2018 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node–Positive and High-Risk Lymph Node–Negative Breast Cancer (E5103)Kathy D. Miller, Anne O’Neill, William Gradishar, Timothy J. Hobday, Lori J. Goldstein, Ingrid A. Mayer, Stuart Bloom, Adam M. Brufsky, Amye J. Tevaarwerk, Joseph A. Sparano, Nguyet Anh Le-Lindqwister, Carolyn B. Hendricks, Donald W. Northfelt, Chau T. Dang, George W. Sledge Jr Sep 2018 Journal of Clinical OncologySee moreSee lessThis abstract is currently unavailable
Metastatic Breast Cancer in Kenya: Presentation, Pathologic Characteristics, and Patterns—Findings From a Tertiary Cancer CenterEtoroabasi Ekpe, Asim Jamal Shaikh, Jasmit Shah, Judith S. Jacobson, Shahin Sayed Dec 2019 Journal of Global OncologySee moreSee lessThis abstract is currently unavailable
The Sin of Exclusion: Applicability of Trials Encouraging Omission of Radiation Therapy to Nonwhite Patients With Breast CancerShearwood McClelland III, Eric P. Xanthopoulos, Timur Mitin Nov 2018 Journal of Oncology Practice
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D. Flake II, Anthony Magliocco, Mark Robson, Lee Schwartzberg, Priyanka Sharma, Krystal Brown, Saskia Wehnelt, Ralf Kronenwett, Alexander Gutin, Johnathan Lancaster, Jack Cuzick, William Gradishar Dec 2019 JCO Precision OncologySee moreSee lessThis abstract is currently unavailable
Pathogenic Variants in CHEK2 Are Associated With an Adverse Prognosis in Symptomatic Early-Onset Breast CancerStephanie L. Greville-Heygate, Tom Maishman, William J. Tapper, Ramsey I. Cutress, Ellen Copson, Alison M. Dunning, Linda Haywood, Louise J. Jones, Diana M. Eccles Nov 2020 JCO Precision OncologySee moreSee lessThis abstract is currently unavailable
Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast CancersTess O’Meara, Michal Marczyk, Tao Qing, Vesal Yaghoobi, Kim Blenman, Kimberly Cole, Vasiliki Pelekanou, David L. Rimm, Lajos Pusztai Nov 2020 JCO Precision OncologySee moreSee lessThis abstract is currently unavailable
